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Abstract
Background: Over the past decades, there have been a multitude of reports on the effectiveness of various techniques for the reconstruction and 
obliteration of the mastoid cavity. 
Material and methods: A comparative study on the meatotympanoplasty effectiveness using the auto osteomatrix forte autograft associated with temporal 
fascia and mastoid obliteration with pediculated musculoperiosteal flap in 58 patients after total tympanomastoidectomy and 59 patients after revision 
surgery of the evidation cavity. The patient batches were similar according to age, gender and living environment.
Results: 12 months postoperatively, in all patients of both study groups was determined:  significant decrease of complaints, ameliorated anatomical 
outcomes (small, clean and dry evidation cavity), eradication of the evidation cavity pathology, improvement of the auditory functional results (statistically 
significant increase in the perception of voice on whispering and speech, airway and bone conduction), improvement of the vestibular function and life 
quality.
Conclusions: Meatotympanoplasty with the use of the auto osteomatrix forte autograft when associated with the temporal fascia and the mastoid dislocation 
with pediculated musculoperiosteal flap is a feasible and safe technique for pathology eradication involving the evidation cavity. The use of the autologous 
bone for reconstruction is effective for the stability of the external auditory canal and for the tympanic membrane. It preserves and / or restores hearing, 
and has a lot of advantages: is immediately available in primary and revision surgeries, is economical, does not cause inflammation processes in the body, 
contributes to the growth of the new bone, reduces the risk of infection, resorption and subsequent degradation and improves life quality.
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Introduction
The objectives of mastoidectomy in chronic suppurative 
otitis media with cholesteatoma are: eradication of the dis-
ease, obtaining dry ears, prevention of recurrent pathology 
and the possibility to restore the affected sonic transmission 
mechanism. Canal wall down mastoidectomy (CWD) is one 
of the commonly used surgical techniques for the effective 
eradication of the middle ear disease. This approach is ag-
gressive with the removal of affected anatomical structures. 
Thus, it leads to an open cavity formation, in this way chan-
ging middle ear anatomy and physiology. Although most pa-
tients experience postoperative minor short-term problems, 
there are a considerable number of patients with chronic dis-
orders associated with the evidation cavity persistence [1].
Otorrhea and recurrent infections are the commonest 
causes of frequent complaints of patients with mastoid cavi-
ties. Other frequent complaints include water intolerance 
with the development of infections, frequent need for oto-
microscopic treatment and removal of pathological secre-
tions, dizziness caused by exposure to water or air, baromet-
ric induced dizziness, and hearing loss with the inability of 
wearing the traditional hearing aids [1].
Reconstruction techniques of the posterior wall of the 
external auditory canal (EAC) and the methods of mastoid 
cavity obliteration appeared as an effort to avoid the disad-
vantages of CWD mastoidectomy techniques. Reconstruc-
tion procedures of the posterior wall of the external auditory 
canal (EAC), mastoid cavity obliteration and ossiculoplasty 
may be performed primarily during the same procedure 
along with CWD mastoidectomy or as a secondary proce-
dure for revision of the mastoid cavity with chronic otor-
rhea and hypoacusis [1].
So far, the otosurgeons do not have a unanimous opin-
ion on the optimal material used to restore ear structures 
after the aggressive surgery. Both organic and inorganic ma-
terials currently used in reconstruction surgery, along with 
indisputable advantages, present serious disadvantages. 
More and more specialists tend to use materials obtained 
from bone and autologous cartilage tissue which possess os-
teoinductive properties [1].
Over the last few decades, there have been a large num-
ber of reports on the effectiveness of a variety of mastoid 
cavity techniques. The commonest applied and popular 
techniques are local flaps (muscle, periost or fascia), free 
autologous grafts (bone, cartilage, fat, fascia) or alloplastic 
grafts (hydroxyapatite, silicon, synthetic bones) [1].
The study aim is to evaluate the efficacy of meatotym-
panoplasty with the use of the auto osteomatrix forte graft 
(AOMF) associated with temporal fascia and mastoid obli-
teration with pediculated musculoperiosteal flap in patients 
after total tympanomastoid dissection (ETMT) in compari-
son to patients after revision surgery of the evidation cavity.
Material and methods
To determine the effectiveness of the use of autogenous 
bone grafts with AOMF osteoinductive properties in recon-
struction surgery after ETMT the prospective cohort study 
was conducted which included 2 batches of patients:
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·	Group of patients with ETMT and reconstruction by 
means of the elaborated method included 58 patients: 
28 (48.3%) women and 30 (51.7%) men with mean age 
of 41.83 ± 1.2 years from 24 up to 60 years old) – the 
baseline lot (LB);
·	Group of patients with revision surgery of the evida-
tion cavity and reconstruction by means of the elab-
orated method constituted 59 patients: 30 (50.8%) 
women and 29 (49.2%) men with mean age of 40.44 ± 
1.3 years (from 18 up to 61 years old) – control group 
(LM).
From the study were excluded: patients with malignant 
ear cancer, patients with congenital disorders, patients that 
were not fully investigated preoperatively or postoperatively 
according to the study protocol, patients that did not attend 
the medical check-ups on the schedule, patients that refused 
to participate in the study or abandoned it.
All patients were treated at the Department of Otorhi-
nolaryngology of the Republican Clinical Hospital in Chi-
sinau, during 2005-2014.
We applied meatotympanoplasty with the use of auto 
osteomatrix forte graft associated with temporal fascia 
and mastoid obstruction with pediculated musculoperios-
teal flap. The first variant is used in patients that were not 
previously operated by OMCS. Firstly the mastoid plane is 
opened within the limits of the Chipault triangle. The rec-
tangular bone fragment with the dimensions of 1.5x2.5 cm 
and the thickness of 1 cm (fig. 1 A, B) is cut from the cor-
tical layer. After that typical ETMT is performed (fig. 2). 
When EAC postero-superior wall is removed, 2 fine crests 
are cut into their upper and lower sides. EAC plastic sur-
gery of the skin is not performed. The postoperative cavity 
is treated with Mirocel or with mesh gauzes with antibacte-
rial ointment. The plaque remains opened during 3-5 days 
(time required to prepare the OMF autograft from the bone 
fragment of the cortical layer, extemporary prepared).  Dai-
ly, on the postoperative cavity are performed measures for 
rehabilitation and removal of pathological secretions with 
microscopic revision. For this are applied dressings, swab-
bing with Mirocel, or treatment with mesh gauzes with an-
tibacterial ointment. The reconstruction stage is performed 
on the 4th up to 6th day (depending on the preparation of 
the OMF autograft). The prepared autografts have sufficient 
elasticity and strength to provide the shape and position re-
quired to model the EAC posterior wall. In addition, it offers 
the possibility of bonding the fascicular graft to reconstruct 
the eardrum. On the margins of OMF grafts, longitudinal 
incisions of 1.5-2 mm are made. After attaching the fasci-
cular graft, the EAC postero-superior wall is reconstructed. 
The bonding of OMF grafts is achieved by using the upper 
and lower ridges prepared during the rehabilitation stage 
(fig. 3). In the mastoid cavity is introduced a 5 mm diameter 
policlorvinil perforated drainage tube and the mastoid cav-
ity is obliterated by placing the pediculated musculoperi-
osteal flap taken from the retroauricular area (fig. 4). EAC 
is swabbed with Mirocel or treated with mesh gauzes with 
antibacterial ointment. Plaque is sutured layer by layer.
The second variant is used in patients with ETMT ante-
cedents and with MUO. Until the revision of the evidation 
A B
Fig. 1.  A, B – sampling of the fragment from the cortical layer of mastoid apophysis.
Fig. 2.  Evidation cavity. 
Mastoid cavity after radical mastoidectomy.
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cavity, a bone fragment from the cortical layer is cut to pre-
pare the OMF autograft. After revision, the mastoid cavity 
is swabbed with Mirocel or treated with mesh gauzes with 
antibacterial ointment. The plaque remains opened during 
3-5 days (the time required to prepare the OMF autograft). 
Daily, on the postoperative cavity are performed procedures 
for rehabilitation and removal of pathological secretions 
with microscopic revision. For this are applied dressings, 
swabbing with Mirocel, or treatment with mesh gauzes with 
antibacterial ointment. The reconstruction stage is per-
formed on 4th up to 6th day (depending on the preparation 
of the OMF autograft). The bonding of the OMF graft and 
mastoid obliteration is similar to the first variant. Plaque is 
sutured layer by layer. EAC is treated swabbed with Mirocel 
or mesh gauzes with antibacterial ointment.
To achieve the study objectives, patients underwent a 
complex clinical and paraclinical examination program ac-
cording to pre-established research designs (at the onset of 
the study and in dynamics at 1, 6, and 12 months postopera-
tively). In the study were applied the following methods of 
investigation: clinical, functional, instrumental, imagistic, 
and microbiologic.
Patient examination protocol included: (1) history of the 
disease taking into consideration the duration and severity 
of the symptoms (otorrhea, hearing loss, tinnitus, dizziness, 
otalgia, cephalalgia) and previous surgical procedures, (2) 
otomicroscopic and /or otoendoscopic examination, (3) 
complete audiological evaluation (audiometry, instrumen-
tal audiometry with diapason,  Liminal pure-tone audiom-
etry, acoustic impedancemetry) (4), vestibular function test, 
(5) temporal bone imaging examination by high resolution 
computerized tomography, life quality assessment by apply-
ing the Chronic Ear Survey.
Primary data processing was performed with the help 
of ”Statistical Package for the Social Sciences” program, 
version 20.0 for Windows (SPSS, Inc., Chicago, IL, 2011) 
using descriptive and inferential statistics. The X² method 
was used with Yates correlation or Fisher’s exact method to 
compare discrete variables, unifactorial variance analysis 
with the application of post-hoc analysis test, the difference 
between the mean values in the study batches, correlation 
analysis to determine the relationship between variables, 
power and direction.
Results
Comparative examination of patients from LB and LM 
groups did not reveal significant statistic differences accord-
ing to: age (40.44±1,3 years and 41.83±1,2 years, respec-
tively; p>0.05), gender (50.8% and 48.3% women, p>0,05; 
49.2% and 51.7% men, p>0.05), living environment (52.5% 
and 56.9% rural area, p>0.05; 47.5% and 43.1% urban area, 
p>0.05), rate of unengaged people(8.5% and 13.8%, respec-
tively; p>0.05), smoking (37.3% and 46.6%, respectively; 
p>0.05) and alcohol consumption (28.8% and 39.7%, re-
spectively; p>0.05).
During the preoperative examination, patients from 
LB group frequently complained of headaches (94.8% and 
78.0%, p <0.05), otalgia (94.8% and 78.0%, p <0.05) and tin-
nitus, 1% and 90.8%, p <0.01). Patients’ general state was 
similar in both study groups. General state of moderate se-
verity constituted 71.2% in LM patients and 81.0% in LB 
patients (p> 0.05).
Hearing test revealed reduced and similar incidence of 
EAC narrowing in patients from both study groups: 8.5% 
of LM patients and 6.9% of LB patients (p> 0.05). Although 
pathological eliminations were identified in all patients in 
both groups, in LB patients were revealed frequent statisti-
cally significant pathological eliminations with fetid odor 
(49.2% and 100.0%, p <0.001), and in LM – odorless path-
ological eliminations without fetid odor (50.8% and 0%, 
p <0.001).
During the objective exam, the postero-superior wall 
was absent statistically significantly more frequently in LM 
patients (100.0% and 0%, p <0.001) was normal (0% and 
89.7%, p <0.001) and protruded (0% 10.3%, p <0.05) more 
frequently in LB. the evidation cavity was recorded only in 
LM patients. The tympanic membrane (TM) was presented 
Fig. 4.  Mastoid obliteration with pediculated  
musculoperiosteal flap.
Fig. 3.  Reconstruction of the postero-superior wall of the 
external auditory canal with the osteomatrix forte graft.
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with perforation and localization in par sensing and pars 
flaccida in all patients from both study groups.
Granulations were present in all patients from both 
study groups. Polyps (22.0% and 43.1%, p <0.05) and cho-
lesteatoma (39.0% and 100.0%, p <0.001) presented statisti-
cally significant incidence in LB patients.
Hearing test revealed: mean value of voice perception 
on whistling (1.95 ± 0.08 m and 1.18 ± 0.04 m, p <0.001), 
mean voice perception during speech (4.24 ± 0 , 09 m and 
3.37 ± 0.07 m, p <0.001), an average decrease of air conduc-
tion duration (49.41 ± 1.1% and 34.14 ± 0.8%, p <0.001) and 
an average decrease in bone conduction (84.41 ± 1.0% and 
60.69 ± 0.6%, p <0.001) significantly higher in LM.
Thus, during the preoperative examination, patients 
from LB group presented more statistically significant inci-
dence of otorrhea with fetid odor, polyps and cholesteatoma. 
Patients from LM group presented pathological elimination 
without fetid odor, and statistically significantly higher au-
diometry tone values.
One month postoperatively, the majority of complaints 
in patients from both study groups were significantly re-
duced. Although, all patients complained of hearing loss 
in both study groups, patients from LB group complained 
of more pronounced statistically significant hearing loss 
(86.4% and 98.3%, p <0.05), and patients from LM group 
complained more frequently of moderate hearing loss (13 , 
6% and 1.7%, p <0.05). The general condition was similar in 
patients from both study groups.
Hearing test revealed statistically significantly higher in-
cidence of moderate otorrhea (22.0% and 54.4%, p <0.001) 
and mild otorrhea (67.8% and 40.4%, p <0.01) was more 
rare in LB patients. The objective examination revealed 
normal postero-superior wall incidence. Perforated and ab-
sent integral MT was similar. Cholesteatoma, granulations 
and adhesions were not found in patients from both study 
groups. The evidation cavity was closed without pathologies 
in all patients from both study groups.
 Hearing test revealed: mean value of voice perception on 
whistling (1.96 ± 0,09 m and 2.88 ± 0,05 m, p <0.001), aver-
age voice perception during speech (4.34 ± 0,1 m and 4.98 
± 0.02 m, p <0.001),  mean loss of air conduction duration 
(44.58 ± 1.7% and 54.83 ± 0.7%, p <0.001) and mean loss 
of osseous conduction duration (77.29 ± 1.5% and 88.97 ± 
1.5%, p <0.001) presented higher statistically significant val-
ues in LB patients.
Thus, 1 month postoperatively, patients from LM group 
complained more frequently of moderate hearing loss and 
patients in LB group – of pronounced hearing loss. The ob-
jective examination revealed more frequent moderate forms 
of otorrhea, and otorrhea in insignificant amount was sta-
tistically significantly less rare in LB patients. Improvement 
of hearing function presented higher statistically significant 
values in patients from LB group.
Six months postoperatively, the complaints frequency 
continued to decline. The complaints frequency and pa-
tients’ general condition were similar in both study groups. 
The general condition of the majority of patients was satis-
factory.
The hearing test did not reveal statistically significant 
differences in the incidence and characteristics of patholog-
ical eliminations. The evidation cavity was closed without 
pathologies in all patients from both study groups.
Hearing test revealed: average voice perception on whis-
pering (2.42 ± 0,1 m and 3.45 ± 0.09 m, p <0.001), average 
voice perception during speech (4.60 ± 0,1 m and 5.95 ± 
0.04 m, p <0.001), mean value of air conduction loss (58.47 
± 0.6% and 65.69 ± 1.5%, p <0.001) and the mean value of 
osseous conduction loss (87.29 ± 0.9% and 92.76 ± 0.3%, 
p <0.001) were statistically significantly higher in patients 
from LB group.
Thus, 6 months postoperatively, the complaints frequen-
cy continued to reduce, and their incidence was the same in 
both study groups. The objective examination did not re-
veal statistically significant differences in the frequency and 
characteristics of pathological eliminations, postero-superi-
or wall, MT, and pathology of the cavity was not found in 
patients in both study groups. The hearing test showed sta-
tistically significantly higher improvement in LB patients.
Although 12 months postoperatively, hypoacusis was 
reported in all patients from both subgroups of study, insig-
nificant hearing loss was more common in patients from LB 
group (11.9% and 41.4%, p <0.001), acute hypoacusis (22.0% 
and 0%, p <0.001) – was statistically significantly more fre-
quent in LM patients. The general condition was satisfactory 
in the majority of patients from both study groups.
The hearing test did not reveal a narrowing of the EAC 
and did not reveal statistically significant differences in the 
incidence and characteristics of the otorrhea and the MT 
state. The condition of the cavity was shown to be closed 
and without pathological changes in all patients from both 
study groups.
The hearing test revealed the average voice perception 
on whispering (3.32 ± 0.1 m and 3.74 ± 0.09 m, p <0.01) 
and the mean value of air conduction loss (62.71 ± 1.7% and 
67.24 ± 1.2%, p <0.05) were statistically significantly higher 
in LB patients.
Thus, 12 months postoperatively, hearing loss was pres-
ent in all patients in both subgroups of study. Insignificant 
hearing loss was more common in LB patients, and sig-
nificant hearing loss was statistically significantly more fre-
quent in LM patients. The mean value of voice perception 
on whispering and the mean value of air conduction loss 
were statistically significantly higher in LB group.
Discussion
 The management of open mastoid cavity has two options: 
conservative and revision surgery with correction (surgery 
for elimination of mastoidectomy adverse effects) [4].
The procedure for the revision surgery of the evidation 
cavity includes the complete elimination of the disease 
and methods for the prevention of recurrent diseases. It 
also includes the reconstruction of EAC posterior wall 
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with meatoplasty, mastoid obliteration procedures, recon-
struction of the tympanic membrane (tympanoplasty), 
reconstruction of the osicular chain (osiculoplasty), and 
meatoplasty [3].
Mercke suggested an innovative procedure in which 
the EAC posterior wall is temporarily removed, in order 
to avoid the disadvantages and combine certain features of 
CWD mastoidectomy. This procedure facilitated the com-
plete removal of the impairment. Subsequently, it is fol-
lowed by the reconstruction using autologous grafts (bone, 
cartilage) or alloplastic grafts (HA cement, ionomeric glass 
cement, titanium plates). This technique, called the canal 
wall reconstruction, with a single step for the removal of 
cholesteatoma and reconstruction of the EAC wall, had long 
acceptable results [5, 6].
Many techniques and materials for grafting (autologous, 
allogeneic, heterologous or synthetic biocompatible) have 
been used in the reconstruction of the posterior wall of 
EAC and mastoid obliteration, but none of these proved to 
be ideal for obliteration. Patient’s tissues are considered to 
be selective materials in reconstruction [2, 7, 8, 9].
In our study, we compared the efficacy of meatotympa-
noplasty with the use of AOMF autograft associated with 
temporal fascia and mastoid dislocation with pediculated 
musculoperiosteal flap in 58 patients after ETMT and in 59 
patients after revision surgery of the evidation cavity. The 
patient batches were similar depending on age, gender, liv-
ing environment, rate of unemployed people, smoking and 
alcohol consumption.
Overall, the dynamic evaluation found more significant 
improvement in LB patients in comparison to LM patients. 
These results coincide with the specialized literature data. 
Kronenberg and co-authors reported the results of a retro-
spective case study of 49 consecutive patients (31 children 
and 18 adults) with the reconstruction of the EAC poste-
rior wall with autologous bone paste and obliteration of 
the mastoid cavity with tympanomeatal flap. After an ave- 
rage 28 months follow-up, 30 primary operated patients 
achieved impermeable ears in 85.7% of cases, dry ears in 
90% of cases, intact MT in 93.3% of cases, and recurrent 
cholesteatoma in 10.0% of cases, compared to 64.7%, 73.7%, 
73.7% and 15.8%, respectively, in 19 patients with second-
ary intervention for the revision of the cavity [11].
A significant complaints reduction (headache, otalgia, 
nausea, dizziness, and general weakness) was determined in 
patients from both study groups, 1 month postoperatively. 
Although all patients had hearing loss in both groups, there 
was statistically significant increase of mild and moderate 
hypoacusis and statistically significant reduction of acute 
hypoacusis. However, the modification rate was higher in 
patients from LB group. Tinnitus and otorrhea were signifi-
cantly statistically reduced after 6 months postoperatively. 
Although at the objective structured primary examination 
the general condition was more severe, the improvement 
rate was higher in LB patients.
The hearing test revealed, in patients from both study 
groups, similar incidence of: narrowed EAC correction, 
otorrhea reduction, disappearance of adhesions, granula-
tions and cholesteatoma, 1 month postoperatively. The 
exanimation of the evidation cavity found, 1 month post-
operatively, a closed cavity in all patients from both study 
groups. 1 month postoperatively almost all pathologies of 
evidation cavity were eradicated, in all patients from both 
study groups. Exception presented desquamation of the 
epidermis and mucositis that significantly statistically de-
creased 1 month and 6 months postoperatively and com-
pletely disappeared after 12 months postoperatively in pa-
tients from LM group.
Patients from both study groups showed a statistically 
significant increase of voice perception on whistling and 
speech and duration of airway and bone conductions. But 
the growth rate was also higher in LB group.
In both study groups the tuning fork samples revealed 
mixed hypoacusis in all patients. Vestibular apparatus ex-
amination revealed a statistically significant improvement. 
Subjective examination using the Likert - CES scale found 
a statistically significant life quality improvement. Statisti-
cally significantly increased the subscale score of activity 
limitation / restriction, symptom subscale score, medical 
resource utilization subscale score, and total score. How-
ever, the rate of life quality improvement was higher in LM 
patients.
Few authors studied the benefits of mastoid obliteration 
with the reconstruction of the external auditory bone canal, 
in particular the improvement of life quality after this pro-
cedure. A recent observational retrospective study was con-
ducted to determine whether the obliteration of the mastoid 
cavity with autologous cranial bone graft after CWD mas-
toidectomy improves the life quality. Primary obliteration 
was performed in 46 patients and secondary obliteration in 
12 patients. The Glasgow Benefit Inventory questionnaire 
was used to estimate the life quality. The overall score and 
subscale scores improved significantly. These results were 
similar to our study data. The authors concluded that the 
mastoid cavity obliteration with the reconstruction of the 
EAC posterior wall with an autologous cranial graft pro-
vides a significant benefit to life quality for both patients 
after primary and secondary interventions [14].
Thus, meatotympanoplasty with the use of auto osteo-
matrix forte autograft associated with temporal fascia and 
pediculated musculoperiosteal flap is a feasible and safe 
technique for eradicating the pathology of the middle ear 
and mastoid cavity. Our preliminary results indicate good 
overall results for the stability of the external auditory canal 
and MT, the preservation and / or improvement of hearing 
and cholesteatoma.
Similar results have been reported in many publica-
tions in the specialized literature.  Mokbel and Khafagy 
presented a prospective case study of 100 adult patients 
(55 males and 45 females) aged between 17-55 years with 
chronic unilateral otitis media with or without cholestea-
toma, without mastoidectomy antecedents, with 12 months 
minimum follow-up period. The authors carried out CWD 
mastoidectomy, extensive meatoplasty, anterior and inferi-
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or canalplasty, tympanoplasty, obliteration with bone paste 
covered by musculoperisteal flap based on three pedicles 
(anterior, lower and upper). The flap and the exposed bone 
were covered with temporal fascia and skin grafts to accel-
erate epithelialization and to obtain a dry cavity. The recon-
struction of the osseous chain was not performed. Twelve 
months postoperatively, 78% of patients had a completely 
dry cavity, 16% had intermittent otorrhea and 6%- persis-
tent otorrhea [10].
Mobashir and co-authors reported the results of the 
study performed on 31 patients (24 men and 7 women) 
with mean age 26.7 years (15 to 36 years old) with   pri-
mary acquired cholesteatoma. The postoperative follow-up 
constituted 15.3 months. The surgical technique included 
complete cortical mastoidectomy, extended posterior tym-
panometry, removal of the posterior bone wall of the EAC, 
dissection and eradication of cholesteatoma, reposition of 
the EAC wall segment in the anatomical area, osiculoplasty 
(in 26 patients), reconstruction of the atical lateral wall with 
autologous bone paste. Postoperatively, all patients pre-
sented a completely healed outer ear canal of almost normal 
size, shape and contour. The posterior wall was stable and 
the bone paste turned into a consistent newbone with the 
texture and integrity of a normal bone canal. None of the 
patients showed residual perforation of MT, otorrhee, myr-
ingitis or prosthesis extrusion [6].
Ghiasi, in a prospective longitudinal study with 28 
months average follow-up, evaluated 56 ears of 48 patients 
with chronic cholecystectomy. After CWD mastoidectomy, 
mixed obliteration of mastoid cavity with autologous bone 
paste was performed. The bone graft was covered with 
a posterior section of the temporal fascia and Pavla flap. 
Seventeen (30%) ears were treated by revision surgery. Ap-
proximately 82% of the ears had a very small, dry, healthy 
mastoid cavity, 13% of ears – occasional otorrhea, 5% of ears 
– granulation tissue, 12.5% of ears – residual cholesteatoma 
and 7% of ears – wound infection [13].
Ramsey and co-authors presented a retrospective clini-
cal study of 60 consecutive surgical interventions at 59 pa-
tients with active OMC aged between 4-84 years (mean age 
of 39 years old), including 53 (88%) ears with cholesteatoma 
and 7 (12%) ears with granulation tissue without cholestea-
toma. All patients underwent CWD mastoidectomy with 
simultaneous thympoplasty. In order to obliterate the mas-
toid cavity, the lower pediculated postauricular  periosteal-
pericraniam flap was used in combination with autologous 
bone paste. Anterior and lower canalplasty and extended 
meatoplasty were performed. The follow-up period consti-
tuted of 12-80 months (on average 32 months). Forty (67%) 
of the procedures were primary and 20 (33%) were revision 
procedures. During all procedures, 54 (90%) patients passed 
successfully the infection control, 6 (10%) patients had re-
peated otorrhea. There were no cases of residual or recur-
rent cholesteatoma [15].
Roberson and co-authors reviewed 62 ears of 57 pa-
tients (25 women and 32 males) after CWD mastoidectomy 
or revision of the problematic mastoid cavity. At the same 
time, 33 patients underwent secondary surgery for os-
sicular reconstruction of 36 ears. Patients were subjected 
to mastoid and epithelium obliteration with autogenous 
cranial bone paste reconstruction, covered with temporal 
fascia. Transplantation of autogenous cranial bones led to 
osteoneogenesis causing complete obliteration of epitym-
panic and mastoid areas with the maintenance of the meso-
thympanic space. Evaluation of long-term outcomes (mean 
period 18.5 months) found: complete bone obliteration in 
95.2% of cases, complete resolution of symptoms in 90% of 
cases, significant reduction in the frequency and severity of 
symptoms in 10% of cases, and assessment of air-bone gap 
≤20 dB in 60% of cases. In 95% of patients Eustachio tube 
functioned properly. None of the patients required a revi-
sion surgery [7].
Beutner and co-authors presented a number of cases 
with 18 patients with the mean age – 46.3-years. These 
patients previously underwent CWD mastoidectomyand 
revision CWD mastoidectomy by obliteration with autolo-
gous bone paste, covered with cartilage plates, meatoplasty 
and MT reconstruction with thin cartilage slices. The av-
erage follow-up period was 6 years. None of the patients 
had residual or recurrent cholesteatoma, did not report 
symptoms similar to preoperative symptoms (otorrhea, 
dizziness), and all patients had dry ears with complete epi-
thelization [12].
Thus, in order to overcome the problem of oversized 
mastoid cavity, reconstruction of the EAC posterior wall 
with immediate mastoid obliteration or revision interven-
tion is performed. Several autologous materials (cartilage, 
bone paste, local pediculated flaps of soft tissue) or synthetic 
biocompatible (bone cement, HA granules, bioactive glass) 
have been used to reduce the size of the cavity. The use of 
the autologous bone contributes to the creation of the new 
bone, reduces the risk of infection, resorption and subse-
quent degradation. It contributes to bone graft survival and 
a lower risk of subsequent repair of the reconstruction com-
pared to heterologous materials. The use of the autologous 
cortical bone to reconstruct the posterior wall of the EAC 
has advantages: it is autologous, immediately available and 
economical, does not develop an inflammatory reaction to a 
foreign body and improves the life quality.
Conclusions
1. Dynamic assessment found a more significant im-
provement of complaints and general condition of patients 
after ETMT and reconstruction by the elaborated method, 
in comparison to patients with revision surgery of the evi-
dation and reconstruction cavity by the elaborated method.
2. Improvement of anatomical outcomes (low, clean and 
dry cavity) and functional outcomes (auditory function, 
vestibular function and life quality) was statistically signifi-
cantly earlier, more stable and with higher rate in patients 
from the control group.
3. Use of the autologous bone for the reconstruction of 
the EAC posterior wall has advantages. It is an autologist; 
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is immediately available in both primary surgery and revi-
sion surgery; is economical; does not develop inflammato-
ry response to the body; contributes to new bone creation; 
reduces the risk of infections, resorption and subsequent 
degradation; contributes to the survival of the graft, re-
stores the almost normal anatomy of EAC; improves the 
life quality.
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